In preventive studies of Company employees in Westphalia, HDL cholesterol was measured in the sera of 4933 men and 2365 women, äs well äs HDL apolipoprotein A-I in the sera of 3509 men and 1648 women. Three subgroups were compared: non-smokers = persons who have never smoked; ex-smokers = persons who do not smoke ät present but did in the past; smokers = persons who sinoke cigarettes at present. Mean values for HDL cholesterol and for HDL apolipoprotein A-I were significantly lower in smokers than in non-smokers or in ex-smokers, while there were no differences between the last two groups. These differences appeared in both sexes but were more pronounced in women than in men. To answer the question whether the observed differences are caused by the consumption of cigarettes by itself or whether they are caused by the presence of othef risk factors, further subgroups were compared to assess the influence of the risk factors obesity, hypertension, hypercholesterolaemia, hyperglycaemia and hyperuricaemia. It was found that -regardless of the presence of no, one, two or more risk factors -the frequency of probands with low HDL cholesterpl values (<0.907 mmöl/1 (men); < 1.166 mmol/1 (women)) was about 10% higher in smokers than in non-smokers or ex-smokers. Subgroups based on the number of risk factors did not exhibit the same clear distribution for apolipoprotein A-I values äs were seen for HDL cholesterol. The results are interpreted in the light of the existing literature. 
Introduction
Serum HDL cholesterol has been measured increasingly in recent years, due to the fact that there is an apparent negative correlation of HDL cholesterol level and coronary risk (1) (2) (3) (4) . It has been demonstrated in various epidemiological studies that cigarette smokers have lower HDL cholesterol levels than non-smokers or ex-smokers (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . On the other hand, there has been little research to date on the potential effects of other components of HDL (e. g. apolipoprotein A-I, apolipoprotein A-II, phosphatidyl choline, sphingomyelin). This is a report on the findings of epidemiological studies (15) on the effect of cigarette smoking on HDL cholesterol and HDL apolipoprotein A-I.
Materials and Methods
A total of 4935 male and 2365 female employees of four different companies in Westphalia were examined in the course of our prospective study of Company employees. Twelve-hour fasting blood samples were taken in the mornings in a specially equipped bus, and were allowed to stand for 30 minutes at room temperature. Serum was obtained by centrifugation at 3000 min" 1 , stored at 4 °C and transported to our laboratories within a maximum of three days. The assays were carried out within 24 hours of receiving the samples. For evaluation purposes, participants in the study were divided into three subgroups, äs follows:
1. non-smokers = individuals who had never smoked before; 2. ex-smokers = individuals who did not smoke at the time, but had been smokers in the past; 3. smokers = individuals who smoked eigarettes at the time of the study. HDL fractions were assayed in the supernatant using the Boehringer Mannheim test (no. 400971) following precipitation of apo·-lipoprotein B^containing lipoproteins by means of phosphotungstic acid/MgCh. HDL cholesterol was enzymatically determined using the CHOD-PAP method (Boehringer Mannheim, combination test no. 187313). HDL apolipoprotein A-I was assayed by kinetic nephelometry, äs described in detail elsewhere (16) .
Results were statistically evaluated using the 2 test or the Kruskal-Wallis test, and by multiple comparison of independent samples by the method of Nemenyi or Duncan. The significance level was set at p <0.05.
Results

The effect of cigarette smoking on HDL cholesterol levels
HDL cholesterol values were distributed log^nor-mally in the total group äs well äs in all considered subgroups. In smokers the HDL cholesterol level was significantly lower than in non-smokers and ex-smokers although no sigriificant differences were observed between non-smokers and ex-smokers (tab. 1). The disparity was apparent in both sexes, being somewhat more pronounced in women than in men. The Proportion of probands with reduced HDL chöleste-rol (< 0.907 mmol/1 in men, < 1.166 mmol/1 in Tab In order to determine whether the number of cigarettes smoked every day influences serum levels of HDL cholesterol, the probands were divided into three groups comprising non-smokers, smokers who smoked up to an average of 20 cigarettes a day, and smokers who smoked more than 20 cigarettes a day. Significant differences were apparent in both men and women between non-smokers on the one hand and moderate and heavy smokers on the other, but not between the two groups of smokers (tab. 5).
Evaluation of other subgroups divided on the basis of daily cigarette consumption showed that there were no disparities in HDL cholesterol levels between non-smokers and very light smokers (up to 5 cigarettes a day), whereas above 5 cigarettes a day the reduced HDL cholesterol values previously described were again apparent. The degree of serum HDL cholestrol reduction was not influenced by the number of cigarettes smoked per day.
Since the mean values of age were different in nonsmokers (36.0 ± 11.5 in men, 37.3 ± 12.6 in women), ex-smokers (41.7 ± 11.4 in men, 33.1 ± 12.6 in women) and smokers (37.3 ± 11.2 in men, 32.0 + 11.5 in women) and risk factors are highly correlated with age, the computations were repeated for agetertiles (under 35, 35-45, over 45 years of age) to eliminate the influence of age.
The findings in the age-tertiles do not differ from those in the total group with respect of differences between smokers, non-smokers and ex-smokers but only with respect to the level of mean values obtained. Therefore, these findings are not presented in detail.
The effect of smoking on serum level of apolipoprotein A-1
Apolipoprotein A-I values were also observed to be significantly lowerin smokers than in non-smokers or ex-smokers, though no clear-cut differences were detected between the latter two groups (tab. 6). The differences observed were more marked among women than men. Subgroups based on the number of risk factors present (tab. 3) did not exhibit the same clear distribution for apolipoprotein A-I values äs were seen for HDL cholesterol (tab. 7). The female smokers with no additional or only one additional risk factor, and the male smokers exhibiting exactly one risk factor, showed HDL apolipoprotein A-I values lower than those of non-smokers and smokers. No statistical difference was evident, however, between male non-smokers and smokers in the subgroup exhibiting no additional risk factors, or between non-smokers and smokers of both sexes with (5, 6, (9) (10) (11) (12) (13) (14) . However, our study was not able to establish any significant differences between the HDL cholesterol values for moderate (<20/day) and heavy (>20/ day) smokers, among either men or women. The negative effect of cigarette smoking becomes more apparent when considered in conjunction with other factors influencing HDL cholesterol level, such äs alcohol consumption (8, 12, 14) , use of oral contraceptives (9, 11, 14) , or physical exercise (7, 17) .
Our own studies show that the differences in HDL cholesterol values between smokers and non-smokers are not attributable to collateral risk factors such äs obesity, hypertension, hypercholesterolaemia, hypertriglyceridaemia, hyperglycaemia, and hyperuricaemia. This is an indication that cigarette smoking in itself leads to a reduction in HDL cholesterol level. This assumption is further supported by the observation of other authors (8, 10) äs well äs our own observations that there are no differences in HDL cholesterol levels between ex-smokers and nonsmokers, and that smokers who quit show an increase in HDL cholesterol level in the space of a few weeks (18) . It cannot be precluded, however, that this rise in HDL cholesterol Tievel is due to the increase in caloric intake, particularly in the form of fat, which is associated with quitting (18) .
Certainly the question of the relevance of the observed effects of cigarette smoking on HDL cholesterol levels is of considerable practical importance. In this regard, it must be borne in mind that the effect of smoking on HDL cholesterol is relatively minor. It must be further taken into consideration that HDL represents a heterogenous group of macromolecules which differ in particle size, chemical composition, and physicocheinical properties. Therefore, it is impossible to determine HDL mass on the basis of HDL cholesterol level and vice versa, particularly in view of the fact that the cholesterol content of HDL varies to between 10 and 20% of the HDL mass. It is in this regard that assaying other components of HDL such äs HDL apolipoprotein A-I and HDL phospholipid öffers additional valuable Information.
It is interesting to note that HDL apolipoprotein A-I values also appear to be lower in smokers than in non-smokers. The differences in HDL apolipoprotein A-I values observed in our study between smokers and non-smokers were, however, in terms of percent, smaller than the differences observed in HDL cholesterol values. This finding is consistent with the results reported by other authors (12, 14, 18) . According to studies by Dedonder-Decoopman et al. (12) the drop in apolipoprotein A-I values also appears to be dependent on the nümber of cigarettes smoked per day. Our studies, however, were not able to establish any significant differences between moderate (<20/day) and heavy (>20/day) smokers.
The epidemiological data presented here leave unanswered the question of the effects of smoking on the metabolism of HDL or any of its components.
